Phase 1 dose- escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias British Journal of Haematology, 05/21/2012

Zeidan AM et al. – The clofarabine (CLO) followed by cyclophosphamide (CY) for four consecutive days (CLO–CYx4) regimen was well tolerated and had activity in patients with relapsed and refractory acute leukaemia (RRAL), especially relapsed acute lymphoblastic leukaemia (ALL). Therefore, CLO–CYx4 can be considered a salvage therapy for adults with RRALs.

Read this article on British Journal of Haematology

Print Article | Back to Articles

Stay current on the latest literature, research and clinical news
Get special communications and offers from MDLinx and our sponsors
Receive invitations to paid market research

View Samples and Register

Stay current - Media Tool

Newsletter

RSS

Facebook

Receive free subspecialty
"5-minute updates" via email

Send the E-mail Newsletter to a Colleague

♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦

♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦

♦ Follow Us on Facebook

Search the latest
Pharmacy Jobs
@MDLinx Career Center
View the full listing of physician jobs

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?